Patent · US Active

Genotype-guided dosing of opioid receptor agonists

US10900082B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 24, 2018
Grant dateJan 26, 2021
Priority date
Expiry dateJan 24, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein, in some aspects, are methods of dosing opioid receptor agonists for treatment of opioid dependence and pain management.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.